Tissue Factor Pathway Inhibitor (TFPI) Antibody

Este producto es parte de TFPI - Tissue factor pathway inhibitor
Product Graph
312€ (60 µl)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Tissue Factor Pathway Inhibitor (TFPI) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx001368
tested applications
WB

Description

TFPI Antibody is a Rabbit Polyclonal antibody against TFPI. This gene encodes a protease inhibitor that regulates the tissue factor (TF)-dependent pathway of blood coagulation. The coagulation process initiates with the formation of a factor VIIa-TF complex, which proteolytically activates additional proteases (factors IX and X) and ultimately leads to the formation of a fibrin clot. The product of this gene inhibits the activated factor X and VIIa-TF proteases in an autoregulatory loop. The encoded protein is glycosylated and predominantly found in the vascular endothelium and plasma in both free forms and complexed with plasma lipoproteins. Several alternatively spliced transcript variants of this gene have been described, but the full-length nature of some of these variants has not been confirmed. [provided by RefSeq, Jul 2008].

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
Tissue Factor Pathway Inhibitor (TFPI)
Host
Rabbit
Reactivity
Human, Mouse, Rat
Recommended Dilution
WB: 1/1000 - 1/2000. Optimal dilutions/concentrations should be determined by the end user.
Clonality
Polyclonal
Conjugation
Unconjugated
Isotype
IgG
Purification
Purified by affinity chromatography.
Size 1
60 µl
Size 2
120 µl
Size 3
200 µl
Form
Liquid
Tested Applications
WB
Buffer
PBS, pH 7.3, containing 0.02% sodium azide, 50% glycerol.
Availability
Shipped within 5-10 working days.
Storage
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Dry Ice
No
UniProt ID
P10646
Gene ID
7035
NCBI Accession
NP_001027452.1
Alias
EPI, LACI, TFI, TFPI1,Extrinsic pathway inhibitor,EPI
Background
Antibody anti-TFPI
Status
RUO
Note
Concentration: 1 mg/ml -

Descripción

Tissue Factor Pathway Inhibitor (TFPI) is a crucial regulator of the extrinsic coagulation cascade, primarily inhibiting the tissue factor (TF)-factor VIIa complex and factor Xa to maintain hemostasis and prevent excessive thrombosis. It is a Kunitz-type serine protease inhibitor, produced mainly by endothelial cells, and circulates bound to lipoproteins or as a free plasma protein. TFPI acts as a feedback inhibitor that ensures balanced thrombin generation, thereby reducing the risk of pathological clot formation. Dysregulation or deficiency in TFPI has been linked to thrombotic disorders and cardiovascular diseases. Beyond its anticoagulant role, TFPI exhibits anti-inflammatory properties, reducing vascular inflammation and protecting against atherosclerosis. It is also involved in angiogenesis and endothelial cell function, making it significant in vascular biology.

Related Products

EH0283

Human TFPI (Tissue factor pathway inhibitor) ELISA Kit

Ver Producto
EHS0011

Horse TFPI (Tissue factor pathway inhibitor) ELISA Kit

Ver Producto
EM1398

Mouse TFPI (Tissue Factor Pathway Inhibitor) ELISA Kit

Ver Producto